Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

6PAG

Killer cell immunoglobulin-like receptor 2DL3 in complex with HLA-C*07:02

6PAG の概要
エントリーDOI10.2210/pdb6pag/pdb
分子名称HLA class I histocompatibility antigen, Cw-7 alpha chain, Beta-2-microglobulin, ARG-TYR-ARG-PRO-GLY-THR-VAL-ALA-LEU, ... (4 entities in total)
機能のキーワードkir receptor, hla, innate immunity, nk cell, t cell, immune system
由来する生物種Homo sapiens (Human)
詳細
タンパク質・核酸の鎖数4
化学式量合計67175.49
構造登録者
Moradi, S.,Rossjohn, J.,Vivian, J.P. (登録日: 2019-06-11, 公開日: 2020-12-16, 最終更新日: 2024-10-23)
主引用文献Moradi, S.,Stankovic, S.,O'Connor, G.M.,Pymm, P.,MacLachlan, B.J.,Faoro, C.,Retiere, C.,Sullivan, L.C.,Saunders, P.M.,Widjaja, J.,Cox-Livingstone, S.,Rossjohn, J.,Brooks, A.G.,Vivian, J.P.
Structural plasticity of KIR2DL2 and KIR2DL3 enables altered docking geometries atop HLA-C.
Nat Commun, 12:2173-2173, 2021
Cited by
PubMed Abstract: The closely related inhibitory killer-cell immunoglobulin-like receptors (KIR), KIR2DL2 and KIR2DL3, regulate the activation of natural killer cells (NK) by interacting with the human leukocyte antigen-C1 (HLA-C1) group of molecules. KIR2DL2, KIR2DL3 and HLA-C1 are highly polymorphic, with this variation being associated with differences in the onset and progression of some human diseases. However, the molecular bases underlying these associations remain unresolved. Here, we determined the crystal structures of KIR2DL2 and KIR2DL3 in complex with HLA-C*07:02 presenting a self-epitope. KIR2DL2 differed from KIR2DL3 in docking modality over HLA-C*07:02 that correlates with variabilty of recognition of HLA-C1 allotypes. Mutagenesis assays indicated differences in the mechanism of HLA-C1 allotype recognition by KIR2DL2 and KIR2DL3. Similarly, HLA-C1 allotypes differed markedly in their capacity to inhibit activation of primary NK cells. These functional differences derive, in part, from KIR2DS2 suggesting KIR2DL2 and KIR2DL3 binding geometries combine with other factors to distinguish HLA-C1 functional recognition.
PubMed: 33846289
DOI: 10.1038/s41467-021-22359-x
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (2.501 Å)
構造検証レポート
Validation report summary of 6pag
検証レポート(詳細版)ダウンロードをダウンロード

252456

件を2026-04-22に公開中

PDB statisticsPDBj update infoContact PDBjnumon